LEGAL LATEST NEWS PHASE 3 DATA OF MDC-IRM FIRST PRODUCT BASED ON MEDINCELL’S TECHNOLOGY, SHOWS SIGNIFICANT IMPROVEMENTS IN PATIENTS WITH SCHIZOPHRENIA Editor Company MedinCell Registration Number 444 606 750 RCS Montpellier Publishing Director Christophe Douat Capital MedinCell is a public limited company with Management and Supervisory Boards (SA à directoire et Conseil de surveillance) with a share capital of 201.109,58 € Address 3 rue des Frères Lumière 34830 Jacou – France Email Address communication@medincell.com Host Host Server OVH Telephone +33 (0) 8 203 203 63 Host Server Address 2 Rue Kellermann 59100 Roubaix France Intellectual Property The presentation and each element of the MedinCell website including trademarks, logos, photographs, domain names, any graphical element belong exclusively to MedinCell (with the exception of a few icons) or its licensors and are protected by intellectual property laws Disclaimer Information supplied on medincell.com is for information purposes only and may expressly or implicitly contain certain forward-looking statements concerning MedinCell and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of MedinCell to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. MedinCell does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise. For a discussion of risks and uncertainties which could cause actual results, financial condition, performance or achievements of MedinCell to differ from those contained in the forward-looking statements please refer to the Risk Factors (Facteurs de Risque) section of the 2014 reference document approved by the AMF on September 4, 2018 under the number I. 18-062, which is available on the AMF website (https://www.amf-france.org) or on MedinCell’s website. Subject Partnership Development Scientific collaboration Press and communication Administration People Stay tuned, leave your email I read and accept the privacy policy HOME WHO ARE WE PRODUCT IMPACT NETWORK NEWS INVESTORS CAREERS Copyright © 2021 MedinCell. All rights reserved. | Legal | Privacy | #BetterMedicineForAll | #ImpactHealth | WHO ARE WE PRODUCT IMPACT NETWORK NEWS INVESTORS CAREERS